These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31373068)

  • 1. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B.
    Cabreus P; Swartling C; Rystedt A
    J Dermatol; 2019 Oct; 46(10):874-878. PubMed ID: 31373068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
    Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
    Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
    Swartling C; Naver H; Lindberg M
    Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study.
    Grimstad Ø; Kvammen BØ; Swartling C
    Am J Clin Dermatol; 2020 Oct; 21(5):741-748. PubMed ID: 32761500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics.
    Karlsson-Groth A; Rystedt A; Swartling C
    Clin Auton Res; 2015 Jun; 25(3):161-7. PubMed ID: 25773586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
    Ando Y; Ohshima Y; Yanagishita T; Watanabe H; Tamada Y; Akiyama M; Watanabe D
    J Dermatol; 2022 Jul; 49(7):719-723. PubMed ID: 35393718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
    Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhidrosis Substantially Reduces Quality of Life in Children: A Retrospective Study Describing Symptoms, Consequences and Treatment with Botulinum Toxin.
    Mirkovic SE; Rystedt A; Balling M; Swartling C
    Acta Derm Venereol; 2018 Jan; 98(1):103-107. PubMed ID: 28761964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
    Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin A and B for Palmoplantar Hyperhidrosis.
    Eilertsen T; Kvammen BØ; Grimstad Ø
    Dermatol Ther (Heidelb); 2024 Mar; 14(3):805-811. PubMed ID: 38424385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
    Nawrocki S; Cha J
    J Am Acad Dermatol; 2020 Apr; 82(4):969-979. PubMed ID: 31811879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.